Univar to distribute Pharmaline range

Published: 30-Mar-2012
Ingredients

Includes more than 20 brands for topical applications and solubilisation


Chemicals distributor Univar has added BASF’s legacy Cognis Pharmaline high-purity oleochemicals for topical applications and solubilisation to its portfolio.

There are more than 20 brands in this series for pharmaceutical applications.

Univar has been distributing BASF’s speciality pharmaceutical ingredients in Sweden, Finland, and Norway since 2003 and expanded into the Baltics in 2011.

‘The expanded range will provide high-performance products that meet the specific needs of the pharmaceutical industry,’ said Jochen Seifert, senior key account manager, BASF Pharma.

‘Univar’s extensive on-the-ground distribution network and strong links in the region have given us a valuable insight into this marketplace.’

The Cognis Pharmaline range includes Kolliphor solubilisers and emulsifiers with high bioavailability, Kollisolv monographed solvents, Kolliwax consistency factors and Kollicream emollients with adaptable spreading value and water permeability. They are said to provide high-performance, stable formulation while ensuring an appealing look and feel for the user.

See more

You may also like

Ingredients

CPHI NEWS: Univar announces distribution agreement with Swati Spentose

Read more
For Lidocaine products, including Lidocaine Base and Lidocaine HCI in the US

Trending Articles

  1. Causes and solutions for dark spots in tablet manufacturing Natoli Engineering examines the causes and solutions for dark spots that can halt production
  2. Logical Biological expands its raw pharma material development and supply capabilities with new lab The raw material supplier can now better serve in vitro diagnostic (IVD) manufacturers, as it has a significantly larger operational capacity
  3. Small molecules: big market opportunities The rapid rise of biologic drugs in recent years has been accompanied by a market narrative that suggests that innovation and new treatments will be fuelled by breakthroughs in this area, leading to a decline in the small molecule pipeline. This is far from true, notes Kevin Cook, Chief Executive Officer at Sterling Pharma Solutions; both are increasing and small molecule drugs continue to be a mainstay of many drug development portfolios
  4. Shasun Chemicals and Drugs Limited
  5. Olon Spa Olon Group is a global leader in the development and production of active pharmaceutical ingredients (APIs) for CDMO and generic markets, integrating chemical synthesis and biological processes while always embracing the highest international safety, quality, and environmental standards.

Upcoming event

CPhI Middle East

10–12 December 2024 | Conference | Riyadh, Saudi Arabia See all

You may also like

Ingredients

CPHI NEWS: Univar announces distribution agreement with Swati Spentose

For Lidocaine products, including Lidocaine Base and Lidocaine HCI in the US
Ingredients

Univar Ireland wins National Safety Award

For sixth year running
Ingredients

Univar expands agreement with Innophos

Will distribute Eral-Protek and BCS specialist phosphates in Turkey
Ingredients

Univar completes acquisition of Basic Chemical Solutions

Mark Byrne joins Univar as chief operating officer
Ingredients

Univar expands Benelux business

Will acquire Quaron business in the region by January 2011
Ingredients

Private equity firm invests in Univar

CD&R acquires 42.5% ownership interest
Ingredients

Univar API distribution partnership with Gharda Chemicals ‘a success’

Univar is now commercially distributing Gharda\'s APIs across Europe
Subscribe now